$0.8700
-0.03-3.33%
At close: Nov 13, 4:00 PM EST
$0.9361
0.06617.6%
After Hours: 7:47 PM EST
Marker Therapeutics Inc
MRKRNASDAQ
Marker Therapeutics rose 0.9% from $0.89 to $0.90, behind the S&P 500's +12.3%. Its worst day was Nov 5 (−11.3%), and its low came Oct 14 at $0.89.
Nov 13, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.12 beat the $-0.40 estimate on $1.2M revenue (est. $723,000.00).
+3.5% · S&P 500 0.0%
Marker Therapeutics closed at its highest level of the year, 145.5% above where the year started.
Story events cover the past 12 months · Times ET
+17.7% · S&P 500 −0.3%
Marker Therapeutics shares rose 17.1%, while the S&P 500 fell 2.0%.
+17.1% · S&P 500 −2.0%
EPS of $-0.09 beat the $-0.19 estimate on $1.1M revenue (est. $649,200.00).
−1.5% · S&P 500 −0.5%
Marker Therapeutics shares rose 19.9%, while the S&P 500 rose 0.6%.
+19.9%, the year's best day · S&P 500 +0.6%
EPS of $-0.16 beat the $-0.19 estimate on $0.00 revenue (est. $665,600.00).
−2.1% · S&P 500 −0.1%
Marker Therapeutics shares rose 13.5%, while the S&P 500 fell 0.5%.
+13.5% · S&P 500 −0.5%
EPS of $-0.09 beat the $-0.19 estimate on $0.00 revenue (est. $665,600.00).
+1.8% · S&P 500 −0.5%
Marker Therapeutics closed at its lowest level of the year, 0.2% below where the year started.
−3.8% · S&P 500 −1.1%
Where it ended: a close of $0.90 on Nov 12, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.14, revenue est. $2.2M).
Nothing in the past 12 months.
All MRKR dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MRKR and SPY from Benzinga historical bars. Not investment advice.
